Compare CSTL & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSTL | VEL |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 722.8M | 765.5M |
| IPO Year | 2019 | 2019 |
| Metric | CSTL | VEL |
|---|---|---|
| Price | $33.05 | $15.34 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $45.22 | $20.83 |
| AVG Volume (30 Days) | ★ 319.5K | 184.0K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.98 |
| EPS | N/A | ★ 1.21 |
| Revenue | ★ $344,229,000.00 | N/A |
| Revenue This Year | $8.49 | N/A |
| Revenue Next Year | $10.44 | $17.51 |
| P/E Ratio | ★ N/A | $12.56 |
| Revenue Growth | ★ 3.66 | N/A |
| 52 Week Low | $17.72 | $14.18 |
| 52 Week High | $44.28 | $21.40 |
| Indicator | CSTL | VEL |
|---|---|---|
| Relative Strength Index (RSI) | 47.52 | 49.74 |
| Support Level | $31.44 | $15.09 |
| Resistance Level | $34.23 | $17.99 |
| Average True Range (ATR) | 1.69 | 0.44 |
| MACD | -0.13 | 0.17 |
| Stochastic Oscillator | 21.52 | 90.68 |
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.
Velocity Financial Inc is a United States-based real estate finance company. Company operates in a large fragmented market with substantial demand for financing and limited supply of institutional financing alternative The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.